The main populations of lymphocytes are B cells, T cells and natural killer (NK) cells. They are typically (although not exclusively) associated with adaptive immune responses. Populations of ...

Induces potent and long-lasting immune responses to defined antigens or whole pathogens (particles), mainly through the ...

Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...

lymphocytes are a type of white blood cell that helps the body fight infection. There are two main types of lymphocytes: B-lymphocytes and T-lymphocytes. Of these, there are two types of T-cells ...

GammaDelta Therapeutics has developed a pipeline of novel allogeneic cell therapies based on its Vδ1+ γδ T cell platforms for the treatment of solid tumors and beyond. Gamma delta (γδ) T ...

Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

Researchers have revolutionized cancer immunotherapy by developing a way to grow T cells in the lab that live longer and ...

A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.

Findings indicate that altering glucose metabolism in T cells boosts their therapeutic potential against melanoma, paving the way for improved immunotherapies.

Scientists developed a novel method to grow T cells that survive longer and fight cancer more effectively. By altering their ...

India’s first global CAR T-cell therapy for adult B-cell Non-Hodgkin Lymphoma (B-NHL), a kind of blood cancer that affects the lymphatic system, has ...